Laboratory Corp American Holdings (LH)

Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today does...

Revenue grew 6.9% while operating margins expanded for a sixth consecutive quarter.

What happened? Shares of healthcare diagnostics company Labcorp Holdings (NYSE:LH) jumped 10.3% in the afternoon session after the company reported third-qua...

Labcorp (NYSE:LH) reported third-quarter 2026 revenue growth, margin expansion and double-digit adjusted earnings-per-share growth, prompting the laboratory services company to raise the midpoint of its full-year revenue and earnings outlook. Revenue rose 7% to $3.8 billion in the quarter, while ad

Healthcare diagnostics company Labcorp Holdings (NYSE:LH) reported Q3 2026 results beating Wall Street’s revenue expectations, with revenue up 6.9% year on y...

Healthcare diagnostics company Labcorp Holdings (NYSE:LH) will be reporting earnings this Wednesday before market hours. Here’s what to expect. Labcorp met a...

Wrapping up Q2 earnings, we look at the numbers and key takeaways for the testing & diagnostics services stocks, including Labcorp (NYSE:LH) and its peers. T...

Low-volatility stocks may offer stability, but that often comes at the cost of slower growth and the upside potential of more dynamic companies. Luckily for ...

The government thinks it's been overpaying Labcorp. They plan to stop doing that next year.

Mid-cap stocks often strike the right balance between having proven business models and market opportunities that can support $100 billion corporations. Howe...

Even if a company is profitable, it doesn’t always mean it’s a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest ...

Over the past six months, Labcorp has been a great trade, beating the S&P 500 by 9.5%. Its stock price has climbed to $339.34, representing a healthy 20% inc...

Schechter maintains a $33 million stake after this pre-scheduled sale under a Rule 10b5-1 plan.

Labcorp’s second quarter results were well received by the market, as the company delivered solid revenue growth and exceeded Wall Street’s non-GAAP profit e...

Specialty testing and Central Labs fueled revenue growth and margin expansion.

Labcorp (NYSE:LH) reported second-quarter 2026 revenue growth, margin expansion and higher adjusted earnings, prompting the laboratory services company to raise the midpoint of its full-year revenue and adjusted EPS guidance. Revenue rose 5.8% year over year to $3.7 billion, while adjusted operatin

Healthcare diagnostics company Labcorp Holdings (NYSE:LH) met Wall Street’s revenue expectations in Q2 CY2026, with sales up 5.8% year on year to $3.73 billi...

Specialty testing and Central Labs fueled revenue growth and margin expansion.

Healthcare diagnostics company Labcorp Holdings (NYSE:LH) met Wall Street’s revenue expectations in Q2 CY2026, with sales up 5.8% year on year to $3.73 billi...